Form 8-K - Current report:
SEC Accession No. 0001493152-24-030667
Filing Date
2024-08-08
Accepted
2024-08-08 07:30:20
Documents
17
Period of Report
2024-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52462
2 ex10-1.htm EX-10.1 262685
3 ex10-2.htm EX-10.2 150717
4 ex99-1.htm EX-99.1 12672
5 ex99-1_001.jpg GRAPHIC 12092
  Complete submission text file 0001493152-24-030667.txt   762702

Data Files

Seq Description Document Type Size
6 XBRL PRESENTATION FILE xtnt-20240807_pre.xml EX-101.PRE 22367
7 XBRL LABEL FILE xtnt-20240807_lab.xml EX-101.LAB 34240
8 XBRL SCHEMA FILE xtnt-20240807.xsd EX-101.SCH 3027
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3580
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 241186063
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)